The Chemiluminescence Immunoassay (CLIA) market is witnessing remarkable momentum as healthcare systems worldwide seek advanced, reliable, and high-sensitivity diagnostic solutions. The increasing prevalence of chronic and infectious diseases, growing need for accurate disease detection, continuous improvements in immunoassay reagents, and the rising adoption of automated diagnostic platforms...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek